Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

TherapeuticsMD Company Profile (NYSE:TXMD)

Consensus Ratings for TherapeuticsMD (NYSE:TXMD) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for TherapeuticsMD (NYSE:TXMD)
Show:
DateFirmActionRatingPrice TargetDetailsShare
11/1/2013Stifel NicolausInitiated CoverageBuy$8.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 11/25/2012 forward)